Structures by: Shishkina S. V.
Total: 101
C25H22N4O5S,H2O
C25H22N4O5S,H2O
Journal of Combinatorial Chemistry (2009) 11, 3 508
a=9.153(3)Å b=11.9412(7)Å c=12.0912(16)Å
α=114.907(9)° β=93.676(18)° γ=94.575(14)°
4-(4-Bromo-phenyl)-5a-hydroxy-7,7-dimethyl-3-phenyl-4,5,5a,6,7,8-hexahydro- 1H-1,2,9a-triaza-cyclopenta[a]naphthalen-9-one
C24H24BrN3O2,0.25(C4H10O)
Organic letters (2007) 9, 9 1691-1694
a=36.322(5)Å b=13.144(5)Å c=25.296(5)Å
α=90.000(5)° β=132.682(5)° γ=90.000(5)°
2-Chloro-4-nitroaniline
C6H5ClN2O2
CrystEngComm (2020)
a=3.77550(19)Å b=13.5798(7)Å c=28.5543(14)Å
α=89.503(4)° β=88.612(4)° γ=86.402(4)°
C11H11NO4S
C11H11NO4S
Green Chemistry (2020) 22, 8 2459-2467
a=38.544(4)Å b=5.1102(9)Å c=11.6487(18)Å
α=90° β=90° γ=90°
C11H11NO5
C11H11NO5
Green Chemistry (2020) 22, 8 2459-2467
a=20.486(2)Å b=3.9298(4)Å c=13.6374(12)Å
α=90° β=90° γ=90°
C11H9NO4
C11H9NO4
Green Chemistry (2020) 22, 8 2459-2467
a=20.522(5)Å b=3.8101(12)Å c=26.193(8)Å
α=90° β=102.39(3)° γ=90°
C18H21NO4
C18H21NO4
RSC Advances (2014) 4, 21 10894
a=6.0940(5)Å b=15.4178(15)Å c=17.637(2)Å
α=90.00° β=90.00° γ=90.00°
2(C31H29ClOP),C2H3N,2(Cl)
2(C31H29ClOP),C2H3N,2(Cl)
RSC Advances (2014) 4, 21 10894
a=8.9199(4)Å b=18.9724(8)Å c=17.1673(11)Å
α=90.00° β=100.522(5)° γ=90.00°
C18H21NO4
C18H21NO4
RSC Advances (2014) 4, 21 10894
a=6.1255(6)Å b=11.2180(11)Å c=24.188(2)Å
α=90.00° β=90.00° γ=90.00°
C18H21NO4
C18H21NO4
RSC Advances (2014) 4, 21 10894
a=10.260(3)Å b=5.820(2)Å c=14.060(4)Å
α=90.00° β=98.37(3)° γ=90.00°
C10H8N2OS
C10H8N2OS
CrystEngComm (2019)
a=7.3622(12)Å b=7.8278(13)Å c=9.5248(18)Å
α=73.758(15)° β=69.604(16)° γ=68.658(15)°
C10H8N2O2
C10H8N2O2
CrystEngComm (2019)
a=4.7260(9)Å b=14.633(3)Å c=12.5056(17)Å
α=90° β=93.970(14)° γ=90°
C10H7NO2S
C10H7NO2S
CrystEngComm (2019)
a=11.3493(10)Å b=5.6476(4)Å c=14.2419(10)Å
α=90° β=100.689(8)° γ=90°
4-nitro-o-phenylene-diamine
C6H7N3O2
CrystEngComm (2017)
a=3.6679(7)Å b=10.1769(19)Å c=17.203(3)Å
α=90° β=90° γ=90°
C19H23N3O3
C19H23N3O3
Green Chemistry (2020) 22, 8 2459-2467
a=11.864(3)Å b=11.162(3)Å c=13.889(5)Å
α=90° β=99.31(3)° γ=90°
C183H190N24O64S8
C183H190N24O64S8
RSC Adv. (2016) 6, 19 16087
a=21.5619(7)Å b=11.3649(4)Å c=18.9777(7)Å
α=90.00° β=93.367(3)° γ=90.00°
C33H40N4O8S2
C33H40N4O8S2
RSC Adv. (2016) 6, 19 16087
a=13.1522(7)Å b=23.4963(16)Å c=11.0242(5)Å
α=90.00° β=90.00° γ=90.00°
C10H26N6Ni,2(ClO4)
C10H26N6Ni,2(ClO4)
CrystEngComm (2014) 16, 18 3707
a=16.3018(5)Å b=8.6598(2)Å c=13.5660(4)Å
α=90.00° β=112.177(4)° γ=90.00°
C161H265N27Ni3O34
C161H265N27Ni3O34
CrystEngComm (2014) 16, 18 3707
a=12.9588(4)Å b=15.3239(5)Å c=24.3358(9)Å
α=78.225(3)° β=84.909(3)° γ=70.031(3)°
C2H5N5
C2H5N5
CrystEngComm (2010) 12, 3 909
a=6.1601(5)Å b=5.9993(5)Å c=11.3396(8)Å
α=90.00° β=93.849(6)° γ=90.00°
Methyl 4-amino-3-phenylisothiazole-5-carboxylate
C11H10N2O2S
Acta Crystallographica Section C (2021) 77, 1
a=3.9876(5)Å b=10.6511(13)Å c=25.107(2)Å
α=90° β=90° γ=90°
Methyl 4-amino-3-phenylisothiazole-5-carboxylate
C11H10N2O2S
Acta Crystallographica Section C (2021) 77, 1
a=6.9210(9)Å b=7.2371(17)Å c=42.396(8)Å
α=90° β=90° γ=90°
3-Cyclopropyl-5-(3-methyl-[1,2,4]triazolo[4,3-<i>a</i>]pyridin-7-yl)-1,2,4-oxadiazole
C12H11N5O
Acta Crystallographica Section C (2021) 77, 1
a=4.4041(4)Å b=27.8787(18)Å c=9.3533(8)Å
α=90° β=100.816(7)° γ=90°
3-Cyclopropyl-5-(3-methyl-[1,2,4]triazolo[4,3-<i>a</i>]pyridin-7-yl)-1,2,4-oxadiazole
C12H11N5O
Acta Crystallographica Section C (2021) 77, 1
a=12.2191(13)Å b=8.1593(9)Å c=22.788(2)Å
α=90° β=90° γ=90°
3-Cyclopropyl-5-(2-hydrazinylpyridin-3-yl)-1,2,4-oxadiazole
C10H11N5O
Acta Crystallographica Section C (2020) 76, 8
a=8.4476(10)Å b=8.5662(8)Å c=8.6125(8)Å
α=110.812(9)° β=115.048(11)° γ=92.854(9)°
3-Cyclopropyl-5-(2-hydrazinylpyridin-3-yl)-1,2,4-oxadiazole
C10H11N5O
Acta Crystallographica Section C (2020) 76, 8
a=4.8240(11)Å b=8.2685(19)Å c=26.527(10)Å
α=90° β=90° γ=90°
<i>N</i>-(2,6-Dimethylphenyl)-4-hydroxy-2,2-dioxo-1<i>H</i>-2λ^6^,1-\ benzothiazine-3-carboxamide
C17H16N2O4S
Acta Crystallographica Section C (2020) 76, 1 69-74
a=8.3735(3)Å b=8.3735(3)Å c=20.0299(8)Å
α=90° β=90° γ=120°
<i>N</i>-(2,6-Dimethylphenyl)-4-hydroxy-2,2-dioxo-1<i>H</i>-2λ^6^,1-\ benzothiazine-3-carboxamide
C17H16N2O4S
Acta Crystallographica Section C (2020) 76, 1 69-74
a=8.3729(2)Å b=8.3729(2)Å c=20.0206(6)Å
α=90° β=90° γ=120°
3-(5-Phenyl-1,3,4-oxadiazol-2-yl)-2<i>H</i>-chromen-2-one
C17H10N2O3
Acta Crystallographica Section C (2019) 75, 11
a=13.9075(11)Å b=5.1543(5)Å c=18.8010(16)Å
α=90° β=97.772(8)° γ=90°
3-(5-Phenyl-1,3,4-oxadiazol-2-yl)-2<i>H</i>-chromen-2-one
C17H10N2O3
Acta Crystallographica Section C (2019) 75, 11
a=15.611(5)Å b=3.8414(9)Å c=21.974(7)Å
α=90° β=90.74(3)° γ=90°
3-(5-Phenyl-1,3,4-oxadiazol-2-yl)-2<i>H</i>-chromen-2-one
C17H10N2O3
Acta Crystallographica Section C (2019) 75, 11
a=3.9158(8)Å b=17.717(3)Å c=18.832(3)Å
α=90° β=94.670(16)° γ=90°
3-[5-(Pyridin-4-yl)-1,3,4-oxadiazol-2-yl]-2<i>H</i>-chromen-2-one
C16H9N3O3
Acta Crystallographica Section C (2019) 75, 11
a=20.931(2)Å b=3.7708(5)Å c=16.0887(15)Å
α=90° β=90° γ=90°
3-[5-(Pyridin-4-yl)-1,3,4-oxadiazol-2-yl]-2<i>H</i>-chromen-2-one
C16H9N3O3
Acta Crystallographica Section C (2019) 75, 11
a=3.7788(9)Å b=9.9655(17)Å c=16.899(3)Å
α=90° β=93.466(19)° γ=90°
6-Hydroxy-<i>N</i>-(4-methoxyphenyl)-4-oxo-2,4-dihydro-1<i>H</i>-pyrrolo[3,2,1-<i>ij</i>]quinoline-5-carboxamide
C19H16N2O4
Acta Crystallographica Section C (2018) 74, 12
a=16.3612(6)Å b=8.4646(3)Å c=23.6668(12)Å
α=90° β=108.718(5)° γ=90°
6-Hydroxy-<i>N</i>-(4-methoxyphenyl)-4-oxo-2,4-dihydro-1<i>H</i>-pyrrolo[3,2,1-<i>ij</i>]quinoline-5-carboxamide
C19H16N2O4
Acta Crystallographica Section C (2018) 74, 12
a=7.1048(19)Å b=10.0882(16)Å c=11.5171(17)Å
α=73.761(17)° β=87.27(2)° γ=76.48(2)°
<i>N</i>-(Diphenylphosphoryl)-2-methoxybenzamide
C20H18NO3P
Acta Crystallographica Section E Crystallographic Communications (2019) 75, 7 939
a=8.317(2)Å b=12.657(2)Å c=16.763(3)Å
α=90° β=90° γ=90°
3-(3-Phenyl-1<i>H</i>-1,2,4-triazol-5-yl)-2<i>H</i>-1-benzopyran-2-one
C17H11N3O2
Acta Crystallographica Section C (2019) 75, 6 822-832
a=6.8415(7)Å b=10.8931(12)Å c=20.163(2)Å
α=74.965(9)° β=83.815(9)° γ=72.183(10)°
3-(3-Phenyl-1<i>H</i>-1,2,4-triazol-5-yl)-2<i>H</i>-1-benzopyran-2-one
C17H11N3O2
Acta Crystallographica Section C (2019) 75, 6 822-832
a=6.8355(11)Å b=19.512(3)Å c=10.881(2)Å
α=90° β=107.811(19)° γ=90°
3-(3-Phenyl-1<i>H</i>-1,2,4-triazol-5-yl)-2<i>H</i>-1-benzopyran-2-one
C17H11N3O2
Acta Crystallographica Section C (2019) 75, 6 822-832
a=13.0369(8)Å b=13.0804(7)Å c=16.2223(8)Å
α=90° β=90° γ=90°
<i>N</i>-Benzyl-4-hydroxy-1-methyl-2,2-dioxo-1<i>H</i>-2λ6,1-benzothiazine-3-carboxamide
C17H16N2O4S
Acta Crystallographica Section C (2016) 72, 5 411-415
a=5.4764(3)Å b=15.9117(8)Å c=18.3228(10)Å
α=90° β=90° γ=90°
<i>N</i>-Benzyl-4-hydroxy-1-methyl-2,2-dioxo-1<i>H</i>-2λ6,1-benzothiazine-3-carboxamide
C17H16N2O4S
Acta Crystallographica Section C (2016) 72, 5 411-415
a=5.4469(3)Å b=15.8455(10)Å c=18.2412(9)Å
α=90° β=90° γ=90°
C17H14N2O2
C17H14N2O2
Acta Crystallographica Section B (2019) 75, 5
a=4.8956(7)Å b=9.6425(15)Å c=14.958(2)Å
α=103.662(13)° β=94.580(12)° γ=98.382(12)°
C16H12N2O2
C16H12N2O2
Acta Crystallographica Section B (2019) 75, 5
a=4.8281(10)Å b=8.5805(13)Å c=15.436(2)Å
α=96.790(13)° β=95.002(15)° γ=91.404(15)°
C16H11FN2O2
C16H11FN2O2
Acta Crystallographica Section B (2019) 75, 5
a=4.6371(13)Å b=8.957(3)Å c=15.788(6)Å
α=99.88(3)° β=96.61(3)° γ=93.21(3)°
C16H11FN2O2
C16H11FN2O2
Acta Crystallographica Section B (2019) 75, 5
a=4.6995(14)Å b=30.579(8)Å c=8.853(3)Å
α=90° β=92.70(2)° γ=90°
C16H11ClN2O2
C16H11ClN2O2
Acta Crystallographica Section B (2019) 75, 5
a=4.3746(9)Å b=30.823(5)Å c=9.855(3)Å
α=90° β=93.225(17)° γ=90°
C16H11BrN2O2
C16H11BrN2O2
Acta Crystallographica Section B (2019) 75, 5
a=4.1661(2)Å b=31.0277(16)Å c=10.4434(6)Å
α=90° β=92.933(4)° γ=90°
C16H11BrN2O2
C16H11BrN2O2
Acta Crystallographica Section B (2019) 75, 5
a=6.9397(5)Å b=10.2611(8)Å c=20.7644(12)Å
α=90° β=96.919(7)° γ=90°
C16H11IN2O2
C16H11IN2O2
Acta Crystallographica Section B (2019) 75, 5
a=6.9395(2)Å b=10.2583(4)Å c=20.7605(6)Å
α=90° β=96.931(3)° γ=90°
C17H14N2O3
C17H14N2O3
Acta Crystallographica Section B (2019) 75, 5
a=6.9921(13)Å b=10.1424(15)Å c=20.862(3)Å
α=90° β=99.570(16)° γ=90°
,
2(C11H16NO2),C9H8O4,C9H10O4
Acta Crystallographica Section B (2019) 75, 2
a=12.078(2)Å b=30.555(2)Å c=10.2038(9)Å
α=90° β=107.272(12)° γ=90°
Methyl 5-chloro-4-hydroxy-2,2-dioxo-1<i>H</i>-2λ^6^,1-benzothiazine-3-carboxylate
C10H8ClNO5S
Acta Crystallographica Section E (2020) 76, 10 1657-1660
a=11.153(3)Å b=6.8926(15)Å c=14.600(3)Å
α=90° β=97.528(5)° γ=90°
(18-bromo-2,3,5,6,8,9,11,12,14,15-decahydro-1,4,7,10,13,16- benzohexaoxacyclooctadecine)potassium chlorotrioxochromate
C16H23BrKO6,ClCrO3
Acta Crystallographica Section E (2006) 62, 1 m120-m122
a=11.102(3)Å b=14.930(4)Å c=13.552(3)Å
α=90.00° β=94.676(18)° γ=90.00°
1-ethyl-4-hydroxy-2-oxo-1,2-dihydroquinoline-3-carboxylic acid
C12H11NO4
Acta Crystallographica Section E (2002) 58, 3 o254-o256
a=9.278(2)Å b=14.050(4)Å c=8.938(2)Å
α=90.00° β=111.21(3)° γ=90.00°
1-Allyl-4-hydroxy-2-oxo-1,2,5,6,7,8-hexahydroquinoline-3-carboxylic acid
C13H15NO4
Acta Crystallographica Section E (2005) 61, 6 o1833-o1835
a=16.823(4)Å b=7.179(2)Å c=19.847(5)Å
α=90.00° β=90.00° γ=90.00°
Methyl 1-acetonyl-4-hydroxy-2-oxo-1,2-dihydroquinoline-3-carboxylate
C14H13NO5
Acta Crystallographica Section E (2005) 61, 12 o4180-o4182
a=11.084(4)Å b=15.120(5)Å c=8.133(3)Å
α=90.00° β=109.77(3)° γ=90.00°
N-(1-Adamantyl)-4-hydroxy-2-(2-methylpropyl)-2-oxo-1,2-dihydroquinoline-3- carboxamide
C24H30N2O3,0.5C3H8O1
Acta Crystallographica Section E (2001) 57, 5 o414-o415
a=15.140(4)Å b=13.655(3)Å c=12.286(3)Å
α=90.00° β=110.51(3)° γ=90.00°
Bis[(18-nitro-2,3,5,6,8,9,11,12,14,15- decahydro-1,4,7,10,13,16-benzohexaoxacyclooctadecine)potassium chlorochromate]
C16H23N1O7,ClCrO3
Acta Crystallographica Section E (2006) 62, 8 m1988-m1989
a=8.7780(10)Å b=9.5310(10)Å c=13.6780(10)Å
α=100.959(9)° β=98.728(9)° γ=98.782(9)°
C28H18N2O6,2.5C2HF3O2,0.5C6H6O
C28H18N2O6,2.5C2HF3O2,0.5C6H6O
Acta Crystallographica Section C (1999) 55, 11 1911-1913
a=8.905(4)Å b=9.497(3)Å c=10.321(5)Å
α=93.83(3)° β=99.90(3)° γ=90.42(3)°
N-(2-Hydroxyphenyl)-N'-phenethylsuccinamide
C18H20N2O3
Acta Crystallographica Section E (2006) 62, 12 o5475-o5476
a=19.630(4)Å b=5.1128(8)Å c=17.326(4)Å
α=90.00° β=114.17(2)° γ=90.00°
2,17-Dibromo-6,7,9,10,12,13- hexahydrodibenzo[b,e][1,4,7,10,13]pentaoxacyclopentadecin monohydrate
C18H18Br2O5,H2O
Acta Crystallographica Section E (2007) 63, 6 o2904-o2904
a=10.012(5)Å b=26.850(5)Å c=7.031(5)Å
α=90° β=101.245(5)° γ=90°
Methyl 5'-acetyl-2'-amino-6'-methyl-2-oxospiro[indoline-3,4'-4H-pyran]-3'-carboxylate
C18H18N2O5
Acta Crystallographica Section E (2007) 63, 7 o3193-o3193
a=24.5506(9)Å b=10.6729(4)Å c=15.8285(7)Å
α=90.00° β=122.818(3)° γ=90.00°
2,3,4,6,7,8,9,10-Octahydropyrimido[1,2-<i>a</i>]azepin-1-ium 2-cyano-1-(2,6-dimethylanilino)-2-(phenylsulfonyl)ethenethiolate
C9H17N2,C17H15N2O2S2
Acta Crystallographica Section E (2008) 64, 1 o255-o255
a=8.3278(5)Å b=11.348(4)Å c=13.661(3)Å
α=104.03(2)° β=92.517(9)° γ=90.635(12)°
2-Bromomethyl-<i>N</i>-isopropyl-7,8-dimethoxy-1,2-dihydro-1,3- oxazolo[3,2-<i>a</i>]quinoline-4-carboxamide
C18H21BrN2O5
Acta Crystallographica Section E (2008) 64, 6 o1031
a=8.736(2)Å b=9.968(2)Å c=10.588(3)Å
α=86.90(2)° β=80.90(2)° γ=80.04(2)°
Catena-Poly[neodymate(III)bis[μ-dimethyl(phenylsulfonyl)amidophosphato]-\ sodium(I)bis[μ-dimethyl(phenylsulfonyl)amidophosphato]]
C32H44N4NaNdO20P4S4
Acta Crystallographica Section E (2007) 63, 12 m3175-m3176
a=20.276(2)Å b=21.9129(9)Å c=22.058(2)Å
α=90.00° β=90.00° γ=90.00°
Ethyl 4-(2-amino-1-cyano-2-oxoethyl)-2-oxo-1-propyl-1,2-dihydroquinoline-3-carboxylate
C18H19N3O4
Acta Crystallographica Section E (2006) 62, 12 o5386-o5387
a=8.2279(15)Å b=10.555(2)Å c=11.701(3)Å
α=116.092(15)° β=94.213(16)° γ=104.475(15)°
4-Hydroxy-1-methyl-2-oxo-1,2-dihydro-quinoline-3-carboxylic acid(4-oxo-2-propyl-4H-quinazolin-3-yl)-amide
C22H20N4O4
Acta Crystallographica Section C (2000) 56, 4 e168-e169
a=12.474(3)Å b=15.213(4)Å c=10.684(3)Å
α=90.00° β=105.95(3)° γ=90.00°
Morpholin-4-ium 2-(5-methyl-1<i>H</i>-1,2,4-triazol-3-ylsulfanyl)acetate
C4H10NO,C5H6N3O2S
Acta Crystallographica Section C (2009) 65, 1 o24-o26
a=12.0500(11)Å b=7.0380(8)Å c=15.6547(14)Å
α=90.00° β=112.559(11)° γ=90.00°
Morpholin-4-ium 2-(5-methyl-1<i>H</i>-1,2,4-triazol-3-ylsulfanyl)acetate
C4H10NO,C5H6N3O2S
Acta Crystallographica Section C (2009) 65, 1 o24-o26
a=9.6912(2)Å b=8.3829(2)Å c=30.1907(8)Å
α=90.00° β=90.00° γ=90.00°
Bis(<i>N</i>-{bis[methyl(phenyl)amino]phosphoryl}-2,2,2- trichloroacetamide)dinitratodioxidouranium(VI)
C32H34Cl6N8O12P2U
Acta Crystallographica Section E (2010) 66, 3 m306
a=10.2180(4)Å b=16.2228(6)Å c=28.4327(7)Å
α=90.00° β=97.421(3)° γ=90.00°
Bis{<i>N</i>-[bis(pyrrolidin-1-yl)phosphoryl]-2,2,2- trichloroacetamide}dinitratodioxidouranium(VI)
C20H34Cl6N8O12P2U
Acta Crystallographica Section E (2010) 66, 3 m322
a=9.8292(7)Å b=10.3436(8)Å c=10.4475(6)Å
α=71.905(6)° β=84.391(5)° γ=71.475(6)°
Ethyl 2-(4-hydroxy-1-methyl-2-oxo-1,2-dihydroquinolin-3-yl)acetate
C14H15NO4
Acta Crystallographica Section E (2009) 65, 5 o968
a=21.608(2)Å b=9.2155(9)Å c=14.6795(12)Å
α=90.00° β=119.632(9)° γ=90.00°
Ethyl 5-[(1<i>H</i>-benzoimidazol-2-yl)aminocarbonyl]-4-hydroxy-2-methyl-6-oxo-\ 1-propyl-1,6-dihydropyridine-3-carboxylate—–ethanol—–methanol (4/2/1)
4(C20H22N4O5),2(C2H6O),CH4O
Acta Crystallographica Section E (2009) 65, 8 o1984
a=10.5527(4)Å b=13.9720(4)Å c=16.0242(5)Å
α=86.804(3)° β=70.980(3)° γ=78.652(3)°
<i>N</i>-{Bis[methyl(phenyl)amino]phosphoryl}-2,2,2-trichloroacetamide
C16H17Cl3N3O2P
Acta Crystallographica Section E (2009) 65, 11 o2812
a=12.8226(10)Å b=19.5161(15)Å c=15.1132(12)Å
α=90.00° β=93.345(6)° γ=90.00°
Tris{<i>N</i>-[bis(pyrrolidin-1-yl)phosphoryl]- 2,2,2-trichloroacetamide}trichloridoerbium(III)
C30H51Cl12ErN9O6P3
Acta Crystallographica Section E (2010) 66, 4 m447
a=15.285(5)Å b=19.442(5)Å c=20.283(5)Å
α=95.461(5)° β=91.937(5)° γ=106.405(5)°
Methyl 2-(4-hydroxy-1-methyl-2-oxo-1,2-dihydroquinolin-3-yl)acetate
C13H13NO4
Acta Crystallographica Section E (2010) 66, 12 o3195
a=9.0792(6)Å b=11.4904(6)Å c=11.4071(7)Å
α=90.00° β=105.272(7)° γ=90.00°
(<i>RS</i>)-2-Oxo-4-(1-phenylethylamino)-1,2-dihydroquinoline-3-carboxylic acid
C18H16N2O3
Acta Crystallographica Section E (2011) 67, 11 o3054
a=14.612(2)Å b=5.9750(6)Å c=18.014(2)Å
α=90.00° β=110.814(14)° γ=90.00°
(<i>S</i>)-1-(1,3-Benzothiazol-2-yl)-2,2,2-trifluoroethanol
C9H6F3NOS
Acta Crystallographica Section E (2014) 70, 9 o946
a=9.2116(9)Å b=5.5052(4)Å c=10.2279(8)Å
α=90.00° β=107.411(9)° γ=90.00°
Methyl 1-allyl-4-hydroxy-2,2-dioxo-1<i>H</i>-2λ^6^,1-benzothiazine-3-carboxylate
C13H13NO5S
Acta Crystallographica Section E (2013) 69, 11 o1698
a=17.8654(12)Å b=6.9444(5)Å c=21.1462(16)Å
α=90.00° β=90.122(7)° γ=90.00°
6-Ethoxycarbonyl-5,7-dihydroxy-2,3-dihydro-1<i>H</i>- pyrido[3,2,1-<i>ij</i>]quinolinium tribromide
C15H16NO4,Br3
Acta Crystallographica Section E (2013) 69, 1 o82
a=7.6491(8)Å b=9.1729(10)Å c=13.3722(14)Å
α=102.355(9)° β=98.777(9)° γ=98.093(9)°
(<i>R</i>,<i>S</i>)-2'-Amino-6'-methyl-2,5',5'-trioxo-6'<i>H</i>-spiro[indoline-3,4'-pyrano[3,2-<i>c</i>][2,1]benzothiazine]-3'-carbonitrile dimethylformamide monosolvate
C20H14N4O4S,C3H7NO
Acta Crystallographica Section E (2014) 70, 7 o786-o787
a=17.2493(12)Å b=9.6046(5)Å c=27.7664(17)Å
α=90.00° β=90.00° γ=90.00°
6-Hydroxy-1,2-dihydro-4<i>H</i>-pyrrolo[3,2,1-<i>ij</i>]quinolin-4-one
C11H9NO2
Acta Crystallographica Section E (2013) 69, 3 o340
a=7.9987(3)Å b=7.6297(2)Å c=14.3500(4)Å
α=90.00° β=101.386(3)° γ=90.00°
C9H12N5,I
C9H12N5,I
The Journal of organic chemistry (2014) 80, 1 375
a=7.1439(8)Å b=13.6155(16)Å c=11.9858(14)Å
α=90.00° β=105.574(2)° γ=90.00°
C15H16N5,Br
C15H16N5,Br
The Journal of organic chemistry (2014) 80, 1 375
a=10.8441(5)Å b=15.1145(6)Å c=18.7318(8)Å
α=90.00° β=94.4490(10)° γ=90.00°
C22H23N3O2
C22H23N3O2
The Journal of organic chemistry (2019) 84, 18 12148-12156
a=7.8798(7)Å b=11.5501(8)Å c=21.2513(19)Å
α=90° β=100.393(8)° γ=90°
C20H15BrCl2N2O4,CH4O
C20H15BrCl2N2O4,CH4O
Beilstein journal of organic chemistry (2014) 10, 117-126
a=8.8751(7)Å b=10.5764(9)Å c=12.3519(10)Å
α=75.858(5)° β=84.297(5)° γ=76.237(5)°
C13H14BrN3O2
C13H14BrN3O2
Beilstein journal of organic chemistry (2014) 10, 117-126
a=6.9659(3)Å b=7.5441(4)Å c=13.4092(5)Å
α=90.994(4)° β=90.947(4)° γ=106.218(5)°
C9H18N2O2
C9H18N2O2
Journal of Organic Chemistry (2010) 75, 5941-5952
a=9.9889(7)Å b=11.4918(8)Å c=9.6399(7)Å
α=90.00° β=90.00° γ=90.00°
C19H26N2O4
C19H26N2O4
Journal of Organic Chemistry (2010) 75, 5941-5952
a=8.1775(6)Å b=11.2741(8)Å c=11.5261(7)Å
α=74.860(6)° β=71.782(6)° γ=75.209(6)°
C16H21N3O5
C16H21N3O5
Journal of Organic Chemistry (2010) 75, 5941-5952
a=15.128(3)Å b=5.9797(11)Å c=19.539(4)Å
α=90.00° β=107.58(2)° γ=90.00°
C11H20N2O4S
C11H20N2O4S
Journal of Organic Chemistry (2011) 76, 7010-7016
a=20.080Å b=5.978Å c=12.389Å
α=90.00° β=104.40° γ=90.00°
C16H21NO4S
C16H21NO4S
Journal of Organic Chemistry (2011) 76, 7010-7016
a=27.7068(11)Å b=5.8066(2)Å c=21.0351(8)Å
α=90.00° β=103.144(4)° γ=90.00°
C20H23NO5S2
C20H23NO5S2
Journal of Organic Chemistry (2011) 76, 7010-7016
a=7.9436(10)Å b=10.6539(16)Å c=13.268(2)Å
α=107.760(11)° β=107.42° γ=90.00°
C14H19NO3S
C14H19NO3S
Journal of Organic Chemistry (2011) 76, 7010-7016
a=6.6298(2)Å b=7.9932(2)Å c=26.5748(8)Å
α=90.00° β=92.578(3)° γ=90.00°
C2H5N5
C2H5N5
CrystEngComm (2010) 12, 3 909
a=5.3783(12)Å b=11.086(3)Å c=13.580(4)Å
α=90.00° β=90.00° γ=90.00°
C21H20ClN3O2
C21H20ClN3O2
The Journal of organic chemistry (2019) 84, 18 12148-12156
a=12.5401(15)Å b=11.5230(17)Å c=13.5777(18)Å
α=90° β=96.662(10)° γ=90°
C21H20N4O6
C21H20N4O6
Journal of Organic Chemistry (2010) 75, 5941-5952
a=9.9288(10)Å b=12.6735(13)Å c=15.7735(15)Å
α=90.00° β=90.00° γ=90.00°
Mo6O26V2,C4H16CuN4,C2H10N2,2(H4N),4(H2O)
Mo6O26V2,C4H16CuN4,C2H10N2,2(H4N),4(H2O)
Inorganic Chemistry Frontiers (2019) 6, 7 1813
a=8.5468(5)Å b=10.9507(5)Å c=10.9914(4)Å
α=102.267(4)° β=112.333(5)° γ=99.415(5)°
C8H30Cu2Mo6N6O28V2,2(H4N),8(H2O)
C8H30Cu2Mo6N6O28V2,2(H4N),8(H2O)
Inorganic Chemistry Frontiers (2019) 6, 7 1813
a=11.2569(3)Å b=9.1947(2)Å c=21.9132(5)Å
α=90° β=99.328(2)° γ=90°